• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种具有 Siglec-7 表型的成熟 NK-92MI 细胞系对白血病细胞表现出高且可持续的细胞毒性。

A Developed NK-92MI Cell Line with Siglec-7 Phenotype Exhibits High and Sustainable Cytotoxicity against Leukemia Cells.

机构信息

Department of Biotechnology and Laboratory Science in Medicine, School of Biomedical Science and Engineering, National Yang-Ming University, Taipei 112, Taiwan.

Department of Laboratory Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan.

出版信息

Int J Mol Sci. 2018 Apr 4;19(4):1073. doi: 10.3390/ijms19041073.

DOI:10.3390/ijms19041073
PMID:29617289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5979288/
Abstract

Altered sialic acid processing that leads to upregulation of cell surface sialylation is recognized as a key change in malignant tissue glycosylation. This cancer-associated hypersialylation directly impacts the signaling interactions between tumor cells and their surrounding microenvironment, especially the interactions mediated by immune cell surface sialic acid-binding immunoglobulin-like lectins (Siglecs) to relay inhibitory signals for cytotoxicity. First, we obtained a Siglec-7 NK-92MI cell line, NK-92MI-S7N, by separating a group of Siglec-7 cell population from an eight-month-long-term NK-92MI in vitro culture by fluorescence-activated cell sorting (FACS). The effect of Siglec-7 loss on NK-92MI-S7N cells was characterized by the cell morphology, proliferation, and cytotoxic activity via FACS, MTS assay, cytotoxic assay, and natural killer (NK) degranulation assay. We found the expression levels of Siglec-7 in NK-92MI were negatively correlated with NK cytotoxicity against leukemia cells. This NK-92MI-S7N cell not only shared very similar phenotypes with its parental cells but also possessed a high and sustainable killing activity. Furthermore, this Siglec-7 NK line was unexpectedly capable of eliminating a NK-92MI-resistant leukemia cell, THP-1, through enhancing the effector-target interaction. In this study, a NK cell line with high and sustainable cytotoxicity was established and this cell may provide a potential application in NK-based treatment for leukemia patients.

摘要

糖基化是恶性组织中一种关键的变化,其特征为唾液酸加工改变,导致细胞表面唾液酸化上调。这种与癌症相关的高唾液酸化直接影响肿瘤细胞与其周围微环境之间的信号相互作用,特别是免疫细胞表面唾液酸结合免疫球蛋白样凝集素(Siglec)介导的相互作用,这些作用传递细胞毒性的抑制信号。首先,我们通过荧光激活细胞分选(FACS)从 NK-92MI 的八个月体外培养物中分离出一组 Siglec-7 细胞群,获得了 Siglec-7 NK-92MI 细胞系 NK-92MI-S7N。Siglec-7 缺失对 NK-92MI-S7N 细胞的影响通过 FACS、MTS 测定、细胞毒性测定和自然杀伤(NK)脱颗粒测定来表征细胞形态、增殖和细胞毒性活性。我们发现 NK-92MI 中的 Siglec-7 表达水平与 NK 对白血病细胞的细胞毒性呈负相关。这种 NK-92MI-S7N 细胞不仅与其亲本细胞具有非常相似的表型,而且具有高且可持续的杀伤活性。此外,这种 Siglec-7 NK 系出人意料地能够通过增强效应物-靶相互作用来消除 NK-92MI 耐药白血病细胞 THP-1。在这项研究中,建立了一种具有高且可持续细胞毒性的 NK 细胞系,该细胞系可能为基于 NK 的白血病患者治疗提供了一种潜在的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/9e9b914eb369/ijms-19-01073-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/7012747e0e84/ijms-19-01073-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/12a2e0d466ed/ijms-19-01073-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/497b6b307e04/ijms-19-01073-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/d70f16bb647c/ijms-19-01073-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/92c7b4a039ec/ijms-19-01073-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/0b9ad15fcdc9/ijms-19-01073-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/9e9b914eb369/ijms-19-01073-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/7012747e0e84/ijms-19-01073-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/12a2e0d466ed/ijms-19-01073-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/497b6b307e04/ijms-19-01073-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/d70f16bb647c/ijms-19-01073-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/92c7b4a039ec/ijms-19-01073-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/0b9ad15fcdc9/ijms-19-01073-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7910/5979288/9e9b914eb369/ijms-19-01073-g007.jpg

相似文献

1
A Developed NK-92MI Cell Line with Siglec-7 Phenotype Exhibits High and Sustainable Cytotoxicity against Leukemia Cells.一种具有 Siglec-7 表型的成熟 NK-92MI 细胞系对白血病细胞表现出高且可持续的细胞毒性。
Int J Mol Sci. 2018 Apr 4;19(4):1073. doi: 10.3390/ijms19041073.
2
Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.Siglec-7 在肥胖人群的自然杀伤 (NK) 细胞亚群上的表达减少。
Immunol Res. 2017 Oct;65(5):1017-1024. doi: 10.1007/s12026-017-8942-y.
3
Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.无糖:新型免疫治疗方法靶向 Siglecs 和唾液酸以增强自然杀伤细胞对癌症的细胞毒性。
Front Immunol. 2019 May 9;10:1047. doi: 10.3389/fimmu.2019.01047. eCollection 2019.
4
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.Siglec-7/9 受体与配体之间的相互作用影响 NK 细胞依赖的肿瘤免疫监视。
J Clin Invest. 2014 Apr;124(4):1810-20. doi: 10.1172/JCI65899. Epub 2014 Feb 24.
5
Branched I antigens on leukemia cells enhanced sensitivity against natural killer-cell cytotoxicity through affecting the target-effector interaction.白血病细胞上的I型分支抗原通过影响靶细胞与效应细胞的相互作用,增强了对自然杀伤细胞细胞毒性的敏感性。
Transfusion. 2017 Apr;57(4):1040-1051. doi: 10.1111/trf.13982. Epub 2017 Mar 24.
6
Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.Siglec-9 定义并限制了一个对感染 HIV 的细胞具有高细胞毒性的自然杀伤细胞亚群。
PLoS Pathog. 2021 Nov 11;17(11):e1010034. doi: 10.1371/journal.ppat.1010034. eCollection 2021 Nov.
7
Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.Siglec-9 抑制针对 SARS-CoV-2 的抗体依赖的自然杀伤细胞细胞毒性。
mBio. 2023 Feb 28;14(1):e0339322. doi: 10.1128/mbio.03393-22. Epub 2023 Feb 2.
8
TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.TGF-β 通过下调 CD48 表达调节白血病细胞对 NK 靶向的敏感性。
Immunobiology. 2019 Sep;224(5):649-658. doi: 10.1016/j.imbio.2019.07.002. Epub 2019 Aug 9.
9
Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication.自然杀伤细胞亚群上 Siglec-9 表达降低与持续 HBV 复制有关。
Front Immunol. 2018 May 30;9:1124. doi: 10.3389/fimmu.2018.01124. eCollection 2018.
10
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion.糖萼工程揭示了基于 Siglec 的 NK 细胞免疫逃逸机制。
Nat Chem Biol. 2014 Jan;10(1):69-75. doi: 10.1038/nchembio.1388. Epub 2013 Nov 24.

引用本文的文献

1
Potential Roles of Serum Exosomal CD155 and its Impact on NK Cell Immunosuppression in Hepatocellular Carcinoma.血清外泌体CD155在肝细胞癌中的潜在作用及其对自然杀伤细胞免疫抑制的影响
Balkan Med J. 2025 May 5;42(3):242-253. doi: 10.4274/balkanmedj.galenos.2025.2025-1-129.
2
The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of View.急性髓系白血病的免疫治疗:临床视角
Cancers (Basel). 2024 Jun 27;16(13):2359. doi: 10.3390/cancers16132359.
3
Molecular Basis and Role of Siglec-7 Ligand Expression on Chronic Lymphocytic Leukemia B Cells.

本文引用的文献

1
Branched I antigens on leukemia cells enhanced sensitivity against natural killer-cell cytotoxicity through affecting the target-effector interaction.白血病细胞上的I型分支抗原通过影响靶细胞与效应细胞的相互作用,增强了对自然杀伤细胞细胞毒性的敏感性。
Transfusion. 2017 Apr;57(4):1040-1051. doi: 10.1111/trf.13982. Epub 2017 Mar 24.
2
Viewing Siglecs through the lens of tumor immunology.从肿瘤免疫学的视角看待唾液酸结合免疫球蛋白样凝集素
Immunol Rev. 2017 Mar;276(1):178-191. doi: 10.1111/imr.12526.
3
LFA-1 Activation in NK Cells and Their Subsets: Influence of Receptors, Maturation, and Cytokine Stimulation.
Siglec-7 配体在慢性淋巴细胞白血病 B 细胞上的表达的分子基础及其作用。
Front Immunol. 2022 May 31;13:840388. doi: 10.3389/fimmu.2022.840388. eCollection 2022.
4
Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia.实现内在潜力:用于急性髓系白血病的嵌合抗原受体自然杀伤细胞疗法
Cancers (Basel). 2021 Mar 29;13(7):1568. doi: 10.3390/cancers13071568.
5
Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review.慢性髓性白血病——从费城染色体到特异性靶向药物:文献综述
World J Clin Oncol. 2021 Feb 24;12(2):69-94. doi: 10.5306/wjco.v12.i2.69.
6
Identification and functional characterization of a Siglec-7 counter-receptor on K562 cells.鉴定和功能表征 K562 细胞上的 Siglec-7 反向受体。
J Biol Chem. 2021 Jan-Jun;296:100477. doi: 10.1016/j.jbc.2021.100477. Epub 2021 Feb 26.
7
Sialic Acids and Their Influence on Human NK Cell Function.唾液酸及其对人自然杀伤细胞功能的影响。
Cells. 2021 Jan 29;10(2):263. doi: 10.3390/cells10020263.
8
Natural killer cell-based immunotherapy for acute myeloid leukemia.基于自然杀伤细胞的免疫疗法治疗急性髓系白血病。
J Hematol Oncol. 2020 Dec 7;13(1):167. doi: 10.1186/s13045-020-00996-x.
9
Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy.瞄准甜蜜点:糖免疫检查点和 γδ T 细胞在靶向免疫治疗中的作用。
Front Immunol. 2020 Sep 29;11:564499. doi: 10.3389/fimmu.2020.564499. eCollection 2020.
10
NK Cell-Based Immune Checkpoint Inhibition.基于自然杀伤细胞的免疫检查点抑制。
Front Immunol. 2020 Feb 13;11:167. doi: 10.3389/fimmu.2020.00167. eCollection 2020.
自然杀伤细胞及其亚群中的淋巴细胞功能相关抗原-1激活:受体、成熟及细胞因子刺激的影响
J Immunol. 2017 Mar 1;198(5):1944-1951. doi: 10.4049/jimmunol.1601004. Epub 2017 Jan 18.
4
Features of Memory-Like and PD-1(+) Human NK Cell Subsets.记忆样和PD-1(+)人自然杀伤细胞亚群的特征。
Front Immunol. 2016 Sep 14;7:351. doi: 10.3389/fimmu.2016.00351. eCollection 2016.
5
The SHP2-ERK2 signaling pathway regulates branched I antigen formation by controlling the binding of CCAAT/enhancer binding protein α to the IGnTC promoter region during erythroid differentiation.在红细胞分化过程中,SHP2-ERK2信号通路通过控制CCAAT/增强子结合蛋白α与IGnTC启动子区域的结合来调节分支I抗原的形成。
Transfusion. 2016 Nov;56(11):2691-2702. doi: 10.1111/trf.13796. Epub 2016 Sep 7.
6
Constitutively expressed Siglec-9 inhibits LPS-induced CCR7, but enhances IL-4-induced CD200R expression in human macrophages.组成性表达的唾液酸结合免疫球蛋白样凝集素-9抑制脂多糖诱导的CCR7,但增强白细胞介素-4诱导的人巨噬细胞中CD200R的表达。
Biosci Biotechnol Biochem. 2016 Jun;80(6):1141-8. doi: 10.1080/09168451.2016.1146070. Epub 2016 Feb 29.
7
Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.使用基于抗体和聚糖的方法对唾液酸结合免疫球蛋白样凝集素进行治疗靶向
Trends Pharmacol Sci. 2015 Oct;36(10):645-660. doi: 10.1016/j.tips.2015.06.008.
8
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.帕博利珠单抗对比研究者选择的化疗用于伊匹单抗难治性黑色素瘤(KEYNOTE-002):一项随机、对照、2期试验
Lancet Oncol. 2015 Aug;16(8):908-18. doi: 10.1016/S1470-2045(15)00083-2. Epub 2015 Jun 23.
9
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab.接受纳武利尤单抗治疗的既往治疗过的晚期肾细胞癌患者的生存、持久缓解及长期安全性
J Clin Oncol. 2015 Jun 20;33(18):2013-20. doi: 10.1200/JCO.2014.58.1041. Epub 2015 Mar 30.
10
A red meat-derived glycan promotes inflammation and cancer progression.一种源自红肉的聚糖会促进炎症和癌症进展。
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):542-7. doi: 10.1073/pnas.1417508112. Epub 2014 Dec 29.